HARVARD MANAGEMENT CO INC - Q3 2020 holdings

$1.82 Billion is the total value of HARVARD MANAGEMENT CO INC's 24 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 36.8% .

 Value Shares↓ Weighting
RPRX  ROYALTY PHARMA PLC$618,041,000
-13.3%
14,690,7800.0%33.99%
-44.1%
FB BuyFACEBOOK INCcl a$284,851,000
+638.9%
1,087,633
+540.6%
15.66%
+376.4%
GOOGL BuyALPHABET INCcap stk cl a$229,429,000
+156.2%
156,543
+147.9%
12.62%
+65.2%
PANW BuyPALO ALTO NETWORKS INC$177,743,000
+125.9%
726,221
+112.0%
9.77%
+45.6%
ICE NewINTERCONTINENTAL EXCHANGE IN$116,172,0001,161,137
+100.0%
6.39%
UBER SellUBER TECHNOLOGIES INC$99,260,000
+2.6%
2,720,937
-12.6%
5.46%
-33.8%
SGMS NewSCIENTIFIC GAMES CORP$93,509,0002,678,571
+100.0%
5.14%
QQQ BuyINVESCO QQQ TRunit ser 1$31,469,000
+93.5%
113,262
+72.5%
1.73%
+24.8%
RVMD  REVOLUTION MEDICINES INC$23,330,000
+10.2%
670,3820.0%1.28%
-28.9%
RLAY NewRELAY THERAPEUTICS INC$23,046,000541,124
+100.0%
1.27%
IVV BuyISHARES TRcore s&p500 etf$21,734,000
+10.1%
64,672
+1.4%
1.20%
-29.0%
GLD SellSPDR GOLD TR$21,080,000
-4.9%
119,014
-10.1%
1.16%
-38.7%
GBIO  GENERATION BIO CO$15,649,000
+47.2%
506,2730.0%0.86%
-5.1%
PLRX  PLIANT THERAPEUTICS INC$12,738,000
-30.2%
562,3790.0%0.70%
-55.0%
NCNA SellNUCANA PLCsponsored adr$12,051,000
-22.9%
2,319,780
-19.7%
0.66%
-50.3%
NRIX NewNURIX THERAPEUTICS INC$10,988,000314,762
+100.0%
0.60%
VEA SellVANGUARD TAX-MANAGED INTL FDftse dev mkt etf$7,118,000
-21.2%
174,041
-25.2%
0.39%
-49.2%
IJR SellISHARES TRcore s&p scp etf$3,491,000
-3.5%
49,710
-6.2%
0.19%
-37.9%
VWO BuyVANGUARD INTL EQUITY INDEX Fftse emr mkt etf$3,475,000
+12.2%
80,360
+2.8%
0.19%
-27.7%
IJH SellISHARES TRcore s&p mcp etf$3,436,000
-13.2%
18,544
-16.7%
0.19%
-44.1%
FULC  FULCRUM THERAPEUTICS INC$3,257,000
-56.6%
410,7140.0%0.18%
-72.1%
MGTA  MAGENTA THERAPEUTICS INC$2,262,000
-9.4%
332,6100.0%0.12%
-41.8%
ASAN NewASANA INCcl a$2,187,00075,946
+100.0%
0.12%
DYN NewDYNE THERAPEUTICS INC$2,165,000107,252
+100.0%
0.12%
BNTX ExitBIONTECH SEsponsored ads$0-31,869
-100.0%
-0.18%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ISHARES TR34Q3 202119.4%
VANGUARD TAX-MANAGED INTL FD34Q3 202114.0%
VANGUARD INTL EQUITY INDEX F34Q3 202112.2%
SPDR GOLD TRUST34Q3 20218.7%
ISHARES TR34Q3 20214.9%
META PLATFORMS INC29Q3 202337.6%
VANGUARD SPECIALIZED PORTFOL28Q1 20202.8%
MAGENTA THERAPEUTICS INC21Q2 20231.4%
ALPHABET INC19Q3 202330.4%
ISHARES TR19Q3 20214.4%

View HARVARD MANAGEMENT CO INC's complete holdings history.

Latest significant ownerships (13-D/G)

View HARVARD MANAGEMENT CO INC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-09
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View HARVARD MANAGEMENT CO INC's complete filings history.

Compare quarters

Export HARVARD MANAGEMENT CO INC's holdings